Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Citi |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2013-09-06 15:08:21 |
Versijas komentārs | |
Teksts |
Olainfarm will
Hold Second Quarter 2013 Investor Conference
Webinar
AS „Olainfarm”
invites shareholders, investors, mass media representatives and
other stakeholders to join its second quarter 2013 investor
conference webinar scheduled on September 10, 2013 at 16:00
(EET). Webinar will be
hosted by the member of the management board Salvis Lapiņš. The
presentation will be in English. During the webinar
topics in relation to AS “Olainfarm” latest activities and analysis
of second quarter 2013 financial results will be discussed.
After the
presentation investors will be welcomed to ask
questions. Due to the limited webinar time, please send
in your questions in advance till September 9 to e-mail: kristine.kazaka@nasdaqomx.com.
What is
webinar? How to join the
webinar? Additional
information on the webinar
AS OlainFarm is one of the biggest pharmaceutical companies in
Latvia with 40 years of experience in production of medication and
chemical and pharmaceutical products. A basic principle of
company's operations is to produce reliable and effective top
quality products for Latvia and the rest of the world. Products
made by the Group are being exported to more than 30 countries of
the world, including the Baltics, Russia, other CIS, Europe, Asia,
North America and Australia.
Information
prepared by:
Salvis
Lapins
Member of the
Board
AS
„OlainFarm”
Tel: +371 6 7013
717
e-mail:
Salvis.Lapins@OlainFarm.lv
|
Pielikumi |
|